Join
Guardion Health Sciences Inc. logo

GHSI

NASDAQ

Guardion Health Sciences Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2019
$3.27-0.21 (-6.03%)
News25/Ratings1

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Latest news

25 items

GHSI FAQ

7 questions
  • What does Guardion Health Sciences Inc. do?
    Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular...
  • Where does GHSI stock trade?
    Guardion Health Sciences Inc. (GHSI) is listed on NASDAQ.
  • What sector and industry is GHSI in?
    Guardion Health Sciences Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Guardion Health Sciences Inc. go public?
    Guardion Health Sciences Inc. (GHSI) completed its IPO in 2019.
  • What are analysts saying about GHSI?
    Guardion Health Sciences Inc. has had 1 recent analyst action on file. The most recent action was from Maxim Group: Buy with a $60.00 price target on 2022-03-08. Recent price targets cluster around $60.00.
  • What companies are similar to GHSI?
    Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare GHSI side-by-side with any of them on Quantisnow.
  • How can I track GHSI on Quantisnow?
    Quantisnow aggregates Guardion Health Sciences Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GHSI to receive live email and push alerts on every new disclosure.